Rare case of norethisterone‐induced hepatitis: A case report

We report a case of probable norethisterone‐related liver injury, manifesting as a significant rise in liver transaminases in a 62‐year‐old woman. Upon discontinuation of norethisterone, liver transaminases decreased to normal level within two weeks. Knowledge of rare adverse effects of drugs such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arafa, Eiman A., Dhayabaran, Vasumathi, Omar, Nabil E., Awaisu, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991762/
https://www.ncbi.nlm.nih.gov/pubmed/35425601
http://dx.doi.org/10.1002/ccr3.5687
_version_ 1784683638468640768
author Arafa, Eiman A.
Dhayabaran, Vasumathi
Omar, Nabil E.
Awaisu, Ahmed
author_facet Arafa, Eiman A.
Dhayabaran, Vasumathi
Omar, Nabil E.
Awaisu, Ahmed
author_sort Arafa, Eiman A.
collection PubMed
description We report a case of probable norethisterone‐related liver injury, manifesting as a significant rise in liver transaminases in a 62‐year‐old woman. Upon discontinuation of norethisterone, liver transaminases decreased to normal level within two weeks. Knowledge of rare adverse effects of drugs such as norethisterone is necessary for rapid identification and management, especially in patients with risk factors such as non‐alcoholic liver disease and obesity.
format Online
Article
Text
id pubmed-8991762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89917622022-04-13 Rare case of norethisterone‐induced hepatitis: A case report Arafa, Eiman A. Dhayabaran, Vasumathi Omar, Nabil E. Awaisu, Ahmed Clin Case Rep Case Reports We report a case of probable norethisterone‐related liver injury, manifesting as a significant rise in liver transaminases in a 62‐year‐old woman. Upon discontinuation of norethisterone, liver transaminases decreased to normal level within two weeks. Knowledge of rare adverse effects of drugs such as norethisterone is necessary for rapid identification and management, especially in patients with risk factors such as non‐alcoholic liver disease and obesity. John Wiley and Sons Inc. 2022-04-08 /pmc/articles/PMC8991762/ /pubmed/35425601 http://dx.doi.org/10.1002/ccr3.5687 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Arafa, Eiman A.
Dhayabaran, Vasumathi
Omar, Nabil E.
Awaisu, Ahmed
Rare case of norethisterone‐induced hepatitis: A case report
title Rare case of norethisterone‐induced hepatitis: A case report
title_full Rare case of norethisterone‐induced hepatitis: A case report
title_fullStr Rare case of norethisterone‐induced hepatitis: A case report
title_full_unstemmed Rare case of norethisterone‐induced hepatitis: A case report
title_short Rare case of norethisterone‐induced hepatitis: A case report
title_sort rare case of norethisterone‐induced hepatitis: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991762/
https://www.ncbi.nlm.nih.gov/pubmed/35425601
http://dx.doi.org/10.1002/ccr3.5687
work_keys_str_mv AT arafaeimana rarecaseofnorethisteroneinducedhepatitisacasereport
AT dhayabaranvasumathi rarecaseofnorethisteroneinducedhepatitisacasereport
AT omarnabile rarecaseofnorethisteroneinducedhepatitisacasereport
AT awaisuahmed rarecaseofnorethisteroneinducedhepatitisacasereport

Ejemplares similares